Value creation in Life Sciences 72: What’s a Good Pre-Money Valuation for my Biotech?
Hi💡 Here’s the reality:
Raising money from private investors/HNIs or VCs?
- The former are often happy to pay a premium.
- But when you hit clinical trials and need to raise large amounts of capital, that sky-high valuation can come back to haunt you.
🔹 Don’t price yourself out of the game before it even starts!
Thanks for watching! 👋
Leave a Comments